Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by narmacon Apr 20, 2020 6:47pm
134 Views
Post# 30931935

Plasma may be the best option in the fight against Covid-19.

Plasma may be the best option in the fight against Covid-19.https://www.cnn.com/2020/04/20/opinions/plasma-treatment-covid-19-sepkowitz/index.html

As the relentless rise of Covid-19 cases and deaths continues unabated, treatment options have begun to occupy center stage.
The politically charged rush to hydroxychloroquine initially clouded people's judgment, but the current data is not confusing. The benefit, if any, may be quite modest, and the risk of toxicity is still real.
A second drug, remdesivir, has made a splash and raised hopes, though in the new drug arena, early enthusiasm is common while actual advance is not.
I am one of many specialists who consider one dose of convalescent plasma as the most promising treatment right now. The way it works might seem like a corny World War II movie designed to stir the guys and gals back home: Recovered Covid patients make their way to a medical station and donate their plasma (and its protective antibodies) to help a sick patient.
<< Previous
Bullboard Posts
Next >>